Studies have shown that blocking the SREBP-1 pathway by inhibiting SREBP Cleavage Activating Protein (SCAP) can notably inhibit the progression of diethylnitrosamine-induced hepatocellular carcinoma (HCC) [15]. The gene discussed is SCAP; the disease is hepatocellular carcinoma.